Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum.

Li Q, Li Y, Dai W, Wang S, Xu Y, Li X, Cai S.

BMC Cancer. 2017 Jan 26;17(1):80. doi: 10.1186/s12885-017-3048-4.

2.

Intraoperative radiation therapy for colon and rectal cancers: a clinical review.

Haddock MG.

Radiat Oncol. 2017 Jan 11;12(1):11. doi: 10.1186/s13014-016-0752-1. Review.

3.

Neoadjuvant treatment of rectal cancer: where are we now?

Kalyan A, Rozelle S, Benson A 3rd.

Gastroenterol Rep (Oxf). 2016 Aug;4(3):206-9. doi: 10.1093/gastro/gow017. Epub 2016 Jul 12. No abstract available.

4.

Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: analysis on 1798 patients by prediction model.

Liu WY, Dinapoli N, Wang X, Meldolesi E, Gambacorta MA, Chiloiro G, Ren H, Fang H, Lu NN, Tang Y, Deng L, Wang JY, Jing H, Xiao Q, Feng YR, Li YX, Wang SL, Song YW, Liu YP, Wang WH, Valentini V, Jin J.

Oncotarget. 2016 Jul 19;7(29):46536-46544. doi: 10.18632/oncotarget.10228.

5.

Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: case report.

Florczynski MM, Sanatani MS, Mai L, Fisher B, Moulin DE, Cao J, Louie AV, Pope JE, Leung E.

BMC Cancer. 2016 Mar 22;16:243. doi: 10.1186/s12885-016-2269-2.

6.
7.

Adjuvant chemotherapy for rectal cancer: Is it needed?

Milinis K, Thornton M, Montazeri A, Rooney PS.

World J Clin Oncol. 2015 Dec 10;6(6):225-36. doi: 10.5306/wjco.v6.i6.225. Review.

8.

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer.

Ferrari L, Fichera A.

Gastroenterol Rep (Oxf). 2015 Nov;3(4):277-88. doi: 10.1093/gastro/gov039. Epub 2015 Aug 19. Review.

9.
10.

Advances and challenges in treatment of locally advanced rectal cancer.

Smith JJ, Garcia-Aguilar J.

J Clin Oncol. 2015 Jun 1;33(16):1797-808. doi: 10.1200/JCO.2014.60.1054. Epub 2015 Apr 27. Review.

11.

Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer.

Lu NN, Jin J, Wang SL, Wang WH, Song YW, Liu YP, Ren H, Fang H, Liu XF, Yu ZH, Li YX.

PLoS One. 2015 Apr 27;10(4):e0124601. doi: 10.1371/journal.pone.0124601. eCollection 2015 Apr 27.

12.

Review of systemic therapies for locally advanced and metastatic rectal cancer.

Yaffee P, Osipov A, Tan C, Tuli R, Hendifar A.

J Gastrointest Oncol. 2015 Apr;6(2):185-200. doi: 10.3978/j.issn.2078-6891.2014.112. Review.

13.

Implications of lymph node retrieval in locoregional rectal cancer treated with chemoradiotherapy: a California Cancer Registry Study.

Gill A, Brunson A, Lara P Jr, Khatri V, Semrad TJ.

Eur J Surg Oncol. 2015 May;41(5):647-52. doi: 10.1016/j.ejso.2015.01.037. Epub 2015 Mar 11.

14.

Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades.

Wiegering A, Isbert C, Dietz UA, Kunzmann V, Ackermann S, Kerscher A, Maeder U, Flentje M, Schlegel N, Reibetanz J, Germer CT, Klein I.

BMC Cancer. 2014 Nov 6;14:816. doi: 10.1186/1471-2407-14-816.

15.

The emerging role of neoadjuvant chemotherapy for rectal cancer.

Boland PM, Fakih M.

J Gastrointest Oncol. 2014 Oct;5(5):362-73. doi: 10.3978/j.issn.2078-6891.2014.060. Review.

16.

Evidence based radiation oncology with existing technology.

Isa N.

Rep Pract Oncol Radiother. 2013 Oct 14;19(4):259-66. doi: 10.1016/j.rpor.2013.09.002. eCollection 2013 Oct 14.

18.

Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy.

Kim H, Chie EK, Ahn YC, Kim K, Park W, Yoon WS, Huh SJ, Ha SW.

Cancer Res Treat. 2014 Apr;46(2):148-57. doi: 10.4143/crt.2014.46.2.148. Epub 2014 Apr 22.

19.

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.

O'Connell MJ, Colangelo LH, Beart RW, Petrelli NJ, Allegra CJ, Sharif S, Pitot HC, Shields AF, Landry JC, Ryan DP, Parda DS, Mohiuddin M, Arora A, Evans LS, Bahary N, Soori GS, Eakle J, Robertson JM, Moore DF Jr, Mullane MR, Marchello BT, Ward PJ, Wozniak TF, Roh MS, Yothers G, Wolmark N.

J Clin Oncol. 2014 Jun 20;32(18):1927-34. doi: 10.1200/JCO.2013.53.7753. Epub 2014 May 5.

20.

Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer.

Myerson RJ, Tan B, Hunt S, Olsen J, Birnbaum E, Fleshman J, Gao F, Hall L, Kodner I, Lockhart AC, Mutch M, Naughton M, Picus J, Rigden C, Safar B, Sorscher S, Suresh R, Wang-Gillam A, Parikh P.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):829-36. doi: 10.1016/j.ijrobp.2013.12.028.

Supplemental Content

Support Center